Highlights

MediaPharma S.r.l.
A Company focused on the discovery and development of innovative drugs for the treatment of cancer and other diseases with unmet medical need.

Product pipeline

MediaPharma is committed to developing innovative products designed to safely and effectively treat patients with cancer and other severe diseases and improve their outcomes.

Product

Description

 Status

MP-EV20-ADC

Anti-HER3 Antibody-Drug Conjugate

Preclinical

MP-EV20-89Zr

EV20 conjugated as an immune-PET tracer

Preclinical

MP-1959

Anti-Gal-3BP Antibody

 

Preclinical

MP-1959-ADC

 

Anti-Gal-3BP Antibody-Drug Conjugate

 

Preclinical

MP-EV20/1959

Bispecific antibody against HER-3 and Gal-3BP

Preclinical

MP-ENDOS/1959

Bispecific antibody against Endosialin and Gal-3BP 

Preclinical

MP-LG1 & LG2

Human recombinant therapeutic proteins

Preclinical

MP-Gal-3BP  

Assay kit for Gal-3BP serum/saliva in COVID-19 infected subjects

Preclinical

Company

R&D

Careers

Business